208.69MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of Voyager Therapeutics Inc is 5.00, ranking 132 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 65.36%, representing a quarter-over-quarter increase of 18.22%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.96% of shares outstanding, with 0.34% increase in holdings.
Institutional Shareholding
Shareholder Activity
Neurocrine Biosciences Inc
BlackRock Institutional Trust Company, N.A.
Millennium Management LLC
BlackRock Financial Management, Inc.
Geode Capital Management, L.L.C.